GLPwatch
Trials (2036)
Page 23 of 34.
- Safety and Efficacy of Liraglutide in Parkinson's Disease
- Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes
- Exenatide and Metformin Therapy in Overweight Women With PCOS
- The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
- Short Term Weight Loss With Liraglutide and Metformin in Infertile Obese PCOS Patients
- A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
- Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.
- A Multiple Dose Study of LY3502970 in Healthy Participants
- Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa
- Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients
- A Study of Dulaglutide in Healthy Participants
- Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- Myocardial Protection of Exenatide in AMI
- Liraglutide in Type 1 Diabetes
- Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D
- Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus
- A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes
- A Study of LY3502970 in Participants With Normal and Impaired Renal Function
- Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
- Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
- GLP-1 Medicines and Mental Health Changes
- A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
- Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes
- STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity
- Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)
- A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
- Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care
- Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
- Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome
- Semaglutide in Nonalcoholic Fatty Liver Disease
- Semaglutide Use in Elderly Obese Patients
- A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden
- A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes
- Bioequivalence of Two Liraglutide Formulations in Healthy Volunteers
- A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease
- A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight
- Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
- Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus
- Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
- Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults
- Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus
- Digital Physical Activity Program
- A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
- Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
- Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
- A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
- Effect of Liraglutide on Clock Genes
- Role of Exenatide in NASH-a Pilot Study
- A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus
- A Study of a Weight Loss Intervention in People With Endometrial Cancer
- Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)
- The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin
- Effectiveness of Combined GLP-1 Receptor Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals
- Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
- Safety and Efficacy of Exenatide as Monotherapy
- A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
- 24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine